prednisone has been researched along with nelarabine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Asselin, BL; Briegel, N; Carroll, AJ; Carroll, WL; Chen, Z; Devidas, M; Dunsmore, KP; Eisenberg, N; Esiashvili, N; Gastier-Foster, JM; Hayashi, RJ; Heerema, NA; Hunger, SP; Loh, ML; Rabin, KR; Raetz, EA; Schultz, KR; Winick, NJ; Winter, SS; Wood, BL; Zweidler-Mckay, PA | 1 |
| El Hussein, S; Fang, H; Garcia-Manero, G; Jabbour, E; Jain, N; Kantarjian, H; Khoury, JD; Konoplev, S; Konopleva, M; Maiti, A; Morita, K; Ravandi, F; Sasaki, K; Short, NJ; Takahashi, K; Wang, F | 1 |
1 review(s) available for prednisone and nelarabine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for prednisone and nelarabine
| Article | Year |
|---|---|
Children's Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Asparaginase; Child; Cohort Studies; Disease-Free Survival; Female; Humans; Leucovorin; Male; Methotrexate; Polyethylene Glycols; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Treatment Outcome | 2020 |
2 other study(ies) available for prednisone and nelarabine
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Outcome of T-cell acute lymphoblastic leukemia/lymphoma: Focus on near-ETP phenotype and differential impact of nelarabine.
Topics: Adolescent; Adult; Aged; Allografts; Antigens, CD; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Asparaginase; Bone Marrow; Cell Lineage; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunophenotyping; Male; Mercaptopurine; Methotrexate; Middle Aged; Mutation; Neoplasm Proteins; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prodrugs; Progression-Free Survival; Proportional Hazards Models; Retrospective Studies; Survival Rate; Vincristine; Young Adult | 2021 |